Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioventus Inc Cl A (BVS)

Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bioventus Inc Cl A 4721 EMPEROR BOULEVARD SUITE 100 DURHAM NC 27703 USA

www.bioventus.com Employees: 930 P: 919-474-6700

Sector:

Medical

Description:

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

Key Statistics

Overview:

Market Capitalization, $K 710,107
Enterprise Value, $K 1,004,157
Shares Outstanding, K 82,763
Float, K 55,451
% Float 67.00%
Short Interest, K 1,546
Short Float 1.87%
Days to Cover 6.94
Short Volume Ratio 0.49
% of Insider Shareholders 33.00%
% of Institutional Shareholders 62.94%

Financials:

Annual Sales, $ 573,280 K
Annual Net Income, $ -33,540 K
Last Quarter Sales, $ 138,650 K
Last Quarter Net Income, $ 3,160 K
EBIT, $ 84,980 K
EBITDA, $ 134,540 K

Growth:

1-Year Return -13.77%
3-Year Return 483.67%
5-Year Return -29.56%
5-Year Revenue Growth 78.50%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.15 on 11/04/25
Next Earnings Date 03/10/26 [--]
Earnings Per Share ttm 0.59
EPS Growth vs. Prev Qtr -28.57%
EPS Growth vs. Prev Year 150.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BVS Ratios

Ratio
Price/Earnings ttm 14.54
Price/Earnings forward 13.73
Price/Earnings to Growth N/A
Return-on-Equity % 26.38%
Return-on-Assets % 7.27%
Profit Margin % -5.85%
Debt/Equity 1.56
Price/Sales 1.03
Price/Cash Flow 8.02
Price/Book 3.43
Book Value/Share 2.50
Interest Coverage -0.27
60-Month Beta 0.80
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar